ICYMI, some of this week’s featured content includes a new podcast episode on type 2 inflammation, and articles on Maui Derm NP+PA Fall 2021, the role of nutrition in wound care and more.
Learning to identify some well-disguised drivers of eczema and contact dermatitis can speed patients toward clear or almost clear, according to a presentation at Maui Derm NP+PA Fall 2021.
A study in the Plastic and Reconstructive Surgery journal investigated the role of nutritional intervention in wound care.
In his presentation at Maui Derm NP+PA Fall 2021, Jerry Shapiro, MD, FAAD, shared his treatment protocols for lupus erythematosus, lichen planopilaris, folliculitis decalvans, and dissecting cellulitis.
Is neonatal acne or infantile acne more worrisome? This question and more were brought up during the Acne and Rosacea Update session at Maui Derm NP+PA Fall 2021.
In a grand rounds presentation at the Maui Derm NP+PA Fall 2021 conference, Seemal Desai, MD, FAAD, Raegan Hunt, MD, PhD, Ted Rosen, MD, and Matthew J. Zirwas, MD, discussed some of their challenging cases.
Case-based observations offered clinicians real-world guidance on distinguishing underlying malignancies in the Therapeutic Hotline session at Maui Derm NP+PA Fall 2021.
The investigation of the efficacy of moisturizing ceramide cream vs hydrophilic cream was published in the journal of Dermatologic Therapy.
An article in the Plastic and Reconstructive Surgery journal investigates chronic wound care and the latest news in healing better and faster.
Patients with skin conditions may be more likely to contract the disease but less likely to become severely ill.
Two poster presentations at the EADV 30th annual conference showed the efficacy of roflumilast foam for nonsteroidal treatment of psoriasis or seborrheic dermatitis.
Optimizing rosacea treatment outcomes isn’t only about papules and pustules. Facial erythema needs to be part of an effective management plan.
Data from a pilot study on a new prototype photodynamic therapy device for BCC was shown at the EADV Congress.
The EADV has revealed the findings from a recent survey shows almost half of all European adults have a dermatological condition.
Delgocitinib is the first and only topical JAK/STAT pathway inhibitor in Japan, and recent data suggests it is effective in the management of atopic dermatitis.
In this week’s Pointers with Dr Portela, the 208SkinDoc compares 3 different fluid sunscreens to decided, in his opinion, which works best.
The 11th annual New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium agenda has been released. Click to see what this meeting has to offer.
Investigators also found that patients with alopecia areata were also had significant inflammatory immune injury and vitamin D deficiency when compared to healthy subjects.
In this episode, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and more!
Dermatology Times® welcomes 7 new members to its Editorial Advisory Board
Gear Up for The Science of Skincare Summit
Read this article to see what is being covered at the Science of Skincare annual meeting being held in New York, New York, on November 6, 2021.
The Cosmetic Bootcamp is being held in Chicago, Illinois, December 11, 2021. The agenda for the event contains live patient demos and more.
Two published studies investigated the safety and efficacy of oral sarecycline for the treatment of truncal acne.
A study investigated the role diet habits have in the development, duration, and severity of acne.